<DOC>
	<DOCNO>NCT01472250</DOCNO>
	<brief_summary>This multi-center , prospective observational clinical study . Eligible patient accept generalize chemotherapy accord investigator 's assessment . Information related treatment , include medication , disease condition , expense , etc . periodically collect . Follow-up 2-month interval periodically perform continually collect information disease progression , subsequent treatment survival death completion study . Recruited patient fill questionnaire quality life initiation treatment , Cycle 3 completion first-line treatment .</brief_summary>
	<brief_title>A Prospective Observational Cohort Study Evaluate Treatment Model Medical Economics Advanced Gastric Cancer Chemotherapy Clinical Practice China</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1 . The patient histologically confirm locallyadvanced recurrent and/or metastatic gastric esophagogastric junction adenocarcinoma , miss opportunity surgical excision , make curative therapy impossible . 2 . The informed consent form sign . 3 . A specimen tumor tissue ( puncture biopsy surgical specimen ) available . 4 . ECOG performance status 0 , 1 2 . 5 . The patient 's general condition function important organ allow generalize chemotherapy accord investigator 's judgment 6 . The patient agedâ‰¥18 1 . The patient know allergic study drug . 2 . The patient recruit clinical study plan participate clinical study . 3 . The patient previously accept chemotherapy advance metastatic disease ( patient may recruit previous adjuvant therapy/neoadjuvant therapy complete 6 month inclusion ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Advanced Gastric Cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>quality life</keyword>
	<keyword>treatment expense</keyword>
	<keyword>patient accept first-line chemotherapy</keyword>
</DOC>